Authors:
Weitzman, AL
Shelton, G
Zuech, N
Owen, CE
Judge, T
Benson, M
Sawczuk, I
Katz, A
Olsson, CA
Bagiella, E
Pfaff, C
Newhouse, JH
Petrylak, DP
Citation: Al. Weitzman et al., Dexamethasone does not significantly contribute to the response rate of docetaxel and estramustine in androgen independent prostate cancer, J UROL, 163(3), 2000, pp. 834-837
Authors:
Petrylak, DP
Macarthur, RB
O'Connor, J
Shelton, G
Judge, T
Balog, J
Pfaff, C
Bagiella, E
Heitjan, D
Fine, R
Zuech, N
Sawczuk, I
Benson, M
Olsson, CA
Citation: Dp. Petrylak et al., Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer, J CL ONCOL, 17(3), 1999, pp. 958-967
Authors:
Petrylak, DP
Macarthur, R
O'Connor, J
Shelton, G
Weitzman, A
Judge, T
England-Owen, C
Zuech, N
Pfaff, C
Newhouse, J
Bagiella, E
Hetjan, D
Sawczuk, I
Benson, M
Olsson, C
Citation: Dp. Petrylak et al., Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer, SEMIN ONCOL, 26(5), 1999, pp. 28-33